Roberto Giovanni Carbone | Microbiology | Research Excellence Award

Prof. Dr. Roberto Giovanni Carbone | Microbiology | Research Excellence Award

Prof. Dr. Roberto Giovanni Carbone | Microbiology | Professor at University of Genoa | Italy

Prof. Dr. Roberto Giovanni Carbone is an internationally recognized physician-scientist and academic leader whose career is distinguished by sustained excellence in respiratory medicine, interstitial lung disease, pulmonary hypertension, and lung transplantation, with a strong foundation in clinical science and translational research. Prof. Dr. Roberto Giovanni Carbone received his medical degree from the University of Genoa and completed advanced specialist training in respiratory diseases and respiratory pathophysiology, complemented by a Master’s degree in respiratory medicine at the Royal Brompton Hospital in the United Kingdom and additional postgraduate training programs in pulmonary hypertension, bronchial asthma, chronic obstructive pulmonary disease, and interstitial lung diseases at leading institutions in the United States and Europe, reflecting a broad and rigorous educational background. He currently serves as Professor of Medicine at the University of Genoa School of Medicine and as a senior consultant specializing in interstitial lung disease and pulmonary hypertension, where he has held key academic, clinical, and leadership roles, contributing to patient-centered care, postgraduate medical education, and institutional development. Prof. Dr. Roberto Giovanni Carbone’s research interests focus on idiopathic pulmonary fibrosis, pulmonary hypertension, lung transplantation, connective tissue disease–associated lung disorders, sarcoidosis, systemic scleroderma, and advanced diagnostic and therapeutic strategies in respiratory medicine, supported by strong research skills in clinical trial design, translational research, imaging interpretation, multidisciplinary care models, and evidence-based guideline development.

Academic Profile: ORCID

Featured Publications:

 

 

Hiba Akram | Microbiology | Young Scientist Award

Mrs. Hiba Akram | Microbiology | Young Scientist Award

Senior Lecturer | Shalamar Institute of Health Sciences | Pakistan

Mrs. Hiba Akram is a dedicated researcher and Senior Lecturer in Medical Laboratory Technology whose work spans microbiology, infectious diseases, biotechnology, nutrigenomics, and precision medicine. Her academic and scientific journey reflects a deep commitment to advancing laboratory sciences through high-quality research, evidence-based practice, and innovation in clinical diagnostics. She has contributed to impactful projects exploring enzyme technology, antibiotic resistance, microbial behavior under stress conditions, nutrigenomic interactions in obesity, and cytomorphological patterns in endocrine disorders. Her completed work includes investigations on nano-coupled thermostable enzymes, plasmid elimination dynamics, and diagnostic cytology, while her ongoing studies address public health challenges such as obesity trends, burn wound microbiology, and hygiene-associated infections. Mrs. Hiba Akram has published research in reputable national and international journals and has authored a chapter in a scientific book, further strengthening her growing academic footprint. Her collaborative engagements with leading academic and healthcare institutions support multidisciplinary research, curriculum enhancement, and student mentorship, and she actively participates in international conferences to disseminate findings and expand scientific dialogue. Her research interests continue to evolve toward the intersection of microbiology, biotechnology, and personalized health, integrating genomic and microbial insights to improve clinical outcomes. Through her contributions to teaching, scholarly writing, and innovative research, she remains committed to shaping the future of Medical Laboratory Technology and advancing scientific understanding in fields critical to public health and biomedical science.

Profiles: Scopus | Orcid | Researchgate | Google Scholar

Featured Publications

Gohar, U. F., Shah, Z., Sarwar, J., Akram, H., & Mukhtar, H. (2021). Recent advances in biotechnology in animal health. Veterinary Pathobiology and Public Health, Unique Scientific Publishers, 7.

Farzand, A., Rohin, M. A. K., Awan, S. J., Ahmad, A. M. R., Akram, H., Saleem, T., … (2025). Nutrigenomics of obesity: Integrating genomics, epigenetics, and diet–microbiome interactions for precision nutrition. Life, 15(11), 1658.

Naseer, M. U., Bilal, M., Sonum, S., Kaleem, M., Akram, H., Altaf, Y., Rafeeq, A., … (2025). Cytomorphological spectrum of thyroid nodules diagnosed by fine-needle aspiration cytology in a tertiary care center. Insights – Journal of Life and Social Sciences, 3(3), 180–188.

Akram, H., Shahid, S., Bukhari, H., Iqbal, K., & Asif, M. (2022). Impact of antibiotic withdrawal and starvation conditions on plasmid elimination and consequent loss of resistance. JPMA: The Journal of the Pakistan Medical Association, 72(6), 1053–1056.

Dr. Marwa Nabil Sayed Abdelaziz | Food microbiology | Women Researcher Award

Dr. Marwa Nabil Sayed Abdelaziz | Food microbiology | Women Researcher Award

Dr. Marwa Nabil Sayed Abdelaziz, Kyushu university, Japan

Marwa Nabil Sayed Abdelaziz seems like a strong candidate for the Women Researcher Award based on the information provided. Here’s why she stands out:

Profile 👤

Scopus 

Orcid

Googlescholar

Academic Excellence 🎓

Marwa is currently a Ph.D. student at Kyushu University, specializing in food microbiology and biocontrol. She holds a Master’s degree in Food Hygiene from Cairo University with distinction, showcasing a solid academic foundation.

Innovative Research 💡

Her research focuses on developing biocontrol strategies for foodborne pathogens, which is highly relevant and impactful for food safety. Her involvement in cutting-edge projects like phage genome editing using CRISPR-Cas further demonstrates her innovative approach.

Significant Contributions 🌟

Marwa has made substantial contributions to the field, as evidenced by her publications in high-impact journals and presentations at international conferences. Her work on food safety and hygiene has practical implications for both public health and the food industry.

Recognition and Awards 🏆

She has been awarded a prestigious scholarship by the Egyptian Ministry of Higher Education, highlighting her recognition and potential in her field.

Professional Experience 💼

Marwa’s experience at the Animal Health Research Institute in Egypt and her current research projects reflect a deep commitment to advancing knowledge and practical solutions in food safety.

Overall, Marwa’s achievements, innovative research, and significant contributions align well with the criteria for the Women Researcher Award.

Publication Top Notes 📚

Comparison of prevalence, characterization, antimicrobial resistance and pathogenicity of foodborne Listeria monocytogenes in recent 5 years in Japan

Potential application of phage vB_EfKS5 to control Enterococcus faecalis and its biofilm in food

Isolation, characterization of Enterococcus phages and their application in control of E. faecalis in milk

Applications of bacteriophage in combination with nisin for controlling multidrug-resistant Bacillus cereus in broth and various food matrices

Single and combined application of bacteriophage and cinnamon oils against pathogenic Listeria monocytogenes in milk and smoked salmon

Genetic Characterization, Antibiotic Resistance, and Virulence Genes Profiling of Bacillus cereus Strains from Various Foods in Japan

Effects of EGCg and theaflavins on emetic toxin-producing Bacillus cereus in vitro

Campylobacter jejuni phages: evaluation and enhancement of antibacterial activity and comprehensive characterization

Identification of Enterococcus spp. from food sources by matrix-assisted laser desorption ionization-time of flight mass spectrometry and characterization of virulence factors …

Characterization of selected phages for biocontrol of food-spoilage pseudomonads

Dr. Nitin Pal Kalia | Immunology and Microbiology | Best Researcher Award

Dr. Nitin Pal Kalia | Immunology and Microbiology | Best Researcher Award

Dr. Nitin Pal Kalia, Assistant Professor, National Institute of Pharmaceutical Education and Research Hyderabad, India

🌟 Dr. Nitin Pal Kalia 🌟, an esteemed Assistant Professor at the National Institute of Pharmaceutical Education and Research, Hyderabad, India, is renowned for his groundbreaking research in Immunology and Microbiology 🧬🔬. His innovative work has earned him the prestigious Best Researcher Award 🏆, recognizing his significant contributions to the scientific community 🌐. Dr. Kalia’s research focuses on understanding the immune system’s complexities and developing novel therapeutic strategies to combat infectious diseases 💉🦠. His dedication to advancing pharmaceutical education and research has made him a prominent figure in his field 📚🎓.

👩‍🎓 Profile

Googlescholar, Orcid

📚  Education

🎓 Dr. Nitin Pal Kalia earned his Ph.D. in Biotechnology from the Indian Institute of Integrative Medicine, Jammu, India, under the guidance of Dr. Inshad Ali Khan, Sr. Principal Scientist, from October 2007 to January 2014 🧪. He previously completed his M.Sc. in Biotechnology at Guru Nanak Dev University, Amritsar, Punjab, India, from June 2004 to May 2006, after qualifying the CEEB examination conducted by JNU 🧬. Dr. Kalia’s academic journey reflects his dedication to the field of Clinical Microbiology and Biotechnology 📚🔬.

🔬 Research Experience

📚 Dr. Nitin Pal Kalia is an esteemed Assistant Professor at NIPER, Hyderabad, Telangana, India, since February 4, 2021. 🌟 Previously, he was honored with the Ramalingaswami Fellowship by the Department of Biotechnology, serving at CSIR-IIIM Jammu from August 16, 2019, to February 1, 2021. 🎓 He was a Research Fellow at Lee Kong Chian School of Medicine, NTU Singapore, from October 16, 2015, to August 15, 2019. 🌏 Dr. Kalia also gained valuable experience as a Visiting Fellow at NIAID-NIH Bethesda, USA, from May 16, 2014, to July 31, 2015. 🌟👏

🎓 Trainings

Dr. Nitin Pal Kalia has impressive experience in biotech research. From February to July 2007, he worked as a trainee on a project titled “Cloning and recombinant expression of Rhabdovirus antigens for vaccine development” at Bharat Biotech International Private Limited in Hyderabad under the Biotech Industrial Training Program sponsored by the Department of Biotechnology, Govt. of India 🧬💉. Additionally, from June to July 2005, he was a trainee on a project entitled “Identifying Bacterial Diversity in Natural Environment: a molecular phylogenetic approach” at IHBT-CSIR in Palampur, Himachal Pradesh 🌿🔬.

🏆 Accomplishments

Dr. Nitin Pal Kalia has a distinguished record in biosafety and research. 🏆 He was awarded the Ramalingaswami Re-entry Fellowship (2017-2018) by DBT, India. His expertise includes BSL-3 training from the National University of Singapore (2016) and NIH USA (2014 & 2015). 🧪 He completed hands-on training on laboratory animal care with A*Star Singapore (2015) and holds the IIIM-CSIR award for novel tuberculosis scaffolds (2013). 🦠 Dr. Kalia also received the ICMR-Senior Research Fellowship for his work on Staphylococcus aureus (2010) and was sponsored by DBT for industrial training (2007). 🧬 He qualified JNU’s Biotechnology Entrance Exam in 2004. 🎓

🔬 Doctoral Research & Post-Doctoral Research

Dr. Nitin Pal Kalia focuses on innovative approaches to combat drug-resistant Mycobacterium tuberculosis. His research explores targeting terminal oxidases and cell wall synthesis. Key findings include the use of Q203 to inhibit the respiratory cytochrome bc1 complex and ongoing efforts to identify potent inhibitors for the bd-oxidase. At NIH, he evaluated new chemical entities, profiling them against resistant MTb mutants. During his Ph.D., he discovered capsaicin as an inhibitor of the NorA efflux pump, significantly reducing the invasiveness of Staphylococcus aureus in macrophages. 💊🔬🦠🔍

🔧 Workshops

🌟 Dr. Nitin Pal Kalia has participated in significant workshops, enhancing his expertise in biotechnology and regulatory toxicology. He attended a workshop on “Management of IPR in Biotechnology” in Hyderabad, sponsored by the Department of Biotechnology, Government of India (April 26-27, 2007) 🌱🔬. Additionally, he engaged in an online national workshop on ‘Role of Regulatory Toxicology and Good Laboratory Practice (GLP) in Drug Discovery and Development’ conducted by NIPER, Hyderabad (August 27-28, 2020) 💻💊. These experiences have enriched his knowledge and professional growth in these crucial fields. 📚✨

📝 Abstracts presented in conferences

Dr. Nitin Pal Kalia has made significant contributions to the field of medicinal chemistry. His research includes a 2022 study, where he explored how capsaicin boosts mupirocin’s efficacy against Staphylococcus aureus by inhibiting the MdeA efflux pump. 🧪🔬 In 2013, Dr. Kalia identified novel inhibitors for the multidrug-resistant efflux pump Rv1258c in Mycobacterium tuberculosis. 🦠🔍 His 2010 study highlighted how piperine enhances rifampicin’s protective efficacy against Mycobacterium tuberculosis infection, showcasing its immunomodulatory activity. 🌿🛡️ His work underscores a commitment to advancing antimicrobial and immunomodulatory therapies. 👩‍🔬👨‍🔬

📄 Publications Top Notes

Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of Staphylococcus aureus

Exploiting the synthetic lethality between terminal respiratory oxidases to kill Mycobacterium tuberculosis and clear host infection

Piperine analogs as potent Staphylococcus aureus NorA efflux pump inhibitors

Sulfur rich 2-mercaptobenzothiazole and 1, 2, 3-triazole conjugates as novel antitubercular agents

Piperine as an inhibitor of the MdeA efflux pump of Staphylococcus aureus

Protective efficacy of piperine against Mycobacterium tuberculosis

Antimicrobial and Antimycobacterial Activities of Methyl Caffeate Isolated from Solanum torvum Swartz. Fruit

Targeting the Mycobacterium ulcerans cytochrome bc1:aa3 for the treatment of Buruli ulcer

Boeravinone B, A Novel Dual Inhibitor of NorA Bacterial Efflux Pump of Staphylococcus aureus and Human P-Glycoprotein, Reduces the Biofilm Formation and …

Dual inhibition of the terminal oxidases eradicates antibiotic‐tolerant Mycobacterium tuberculosis